Keyphrases
Breast Cancer
100%
Clinical Utility
100%
Circulating Tumor DNA (ctDNA)
100%
DNA Testing
100%
Metastatic Breast Cancer
57%
Early Breast Cancer
42%
Prognostic Value
28%
Neoadjuvant Setting
28%
Genetic Modification
14%
Cancer Cells
14%
Bloodstream
14%
Curative Treatment
14%
DNA Fragments
14%
Treatment Resistance
14%
Minimal Residual Disease
14%
Clinical Recurrence
14%
Predicting Treatment Response
14%
Medicine and Dentistry
Breast Cancer
100%
Circulating Tumor DNA
100%
Metastatic Breast Cancer
57%
Treatment Response
14%
Cancer Cell
14%
Recurrent Disease
14%
Minimal Residual Disease
14%
DNA Fragment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Circulating Tumor DNA
100%
Metastatic Breast Cancer
57%
Malignant Neoplasm
14%
Recurrent Disease
14%
Minimal Residual Disease
14%
DNA Fragment
14%